Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Trump Executive Allen Weisselberg Gets 5-Month Jail Sentence
Allen Weisselberg was sentenced Tuesday to five months in jail for dodging taxes on $1.7 million in job perks.
Stocks Tick Higher on Wall Street as Inflation Report Looms
Stocks ticked higher in quiet trading on Wall Street Tuesday, ahead of some potentially market-moving reports scheduled for later in the week.
UK Space Industry Mulls Setback After Satellite Launch Fails
British officials and space scientists said Tuesday they were disappointed but not deterred after the first attempt to launch satellites into orbit from the U.K. ended in failure.
Morning Alexa Flash Briefings January 10th
Alexa Flash Briefings
Cheddar Morning News Briefings of January 10th
Cheddar Morning News Briefings
Playing the Bond Market in 2023
Peter Baden, chief investment officer of F/M Investments, joined Cheddar News to discuss how to play the bond market in the new year.
AT&T Digital Landline Customers Won't Be Able to Get the 411 From Now On
AT&T has officially discontinued its nationwide 411 service for digital landlines.
Federal Regulators Are Investigating Musk Tweet on Stopping Safety Alerts
The NHTSA is investigating a Musk tweet indicating Tesla might allow some customers testing the "Full Self-Driving" system to disable an alert that tells them to keep their hands on the wheel.
SEC Charges Former McDonald's Chief Exec With Misleading Investors
The SEC has charged former McDonald's CEO Stephen J. Easterbrook with making "false and misleading statements" to investors about his firing in 2019.
